IGF2BP3 and type 2 diabetes mellitus: The strengths of the present study also included a high‐risk population, the application of nonlinear regression analyses instead of a simple linear test, a novel perspective of serum IGF2BP3 on T2DM prediction, and multivariate adjustment for confounding factors, such as BMI, WC, DBP, TC, and TG.